“Genetic screening helps guide a patient’s physician team to determine if the patient needs additional testing or surveillance and gives the patient the best information to make an informed decision regarding preventive procedures,” says Caroline Peterson, DO, OB/GYN, director of Breast Cancer Screening and Prevention for Kettering Health Network.
Most genetic testing programs in the United States only test for a small number of genes, but the TRAC program uses Myriad Laboratories My Risk technology to screen for more cancer-causing genes—28 in total—and is even able to test for moderately aggressive genes that were just recently discovered.
“Only a handful of healthcare practices in the country are screening at such a comprehensive level,” says Dr. Peterson. “By analyzing a greater number of genes, up to 104 percent more potentially deleterious genes can be identified.”
Kettering Health Network has a genetics counselor who offers services network-wide to help patients understand their results, risks, and treatment options.
“By implementing a network-wide genetic screening program and establishing a baseline for all patients that will be updated annually, we are able to monitor our patients’ health more closely and ultimately see fewer occurrences, and higher survival rates, for all cancers,” says Dr. Peterson.
To learn more about the TRAC program, ask a Kettering Health Network physician. To find out more about cancer care and treatment at Kettering Health Network, visit ketteringhealth.org/cancercare.